VHOSPITAL.CLINIC · Antiparasitic Treatment
Albendazole is the preferred agent over mebendazole for trichinellosis due to better systemic bioavailability, achieving higher tissue concentrations in muscle where larvae encyst.
Unlike mebendazole, albendazole's sulphoxide metabolite achieves significant plasma levels and penetrates muscle tissue, where it inhibits larval tubulin polymerisation and disrupts encystment — making it more effective against systemic trichinellosis.
Adults: 400 mg twice daily for 8–14 days with corticosteroids. Take with fatty food to maximise absorption (bioavailability increases 5-fold with fat). Start within 3 weeks of symptom onset for maximum benefit.
This is a general reference. Always follow your physician's prescription and current treatment guidelines.
Yes, for systemic disease. Albendazole achieves significantly higher muscle tissue concentrations than mebendazole due to better bioavailability, making it the preferred agent when larvae have already invaded muscle.
Treatment duration is typically 8–14 days. Extended courses (up to 4 weeks) may be needed in severe cases. The combination with corticosteroids is maintained throughout to manage inflammation.
The intestinal phase is fully curable. In the muscle phase, antiparasitic treatment reduces larval load and symptoms but encysted larvae remain indefinitely in muscle tissue. Most patients recover fully with treatment.
By treating Trichinellosis, Albendazole addresses these associated symptoms:
Explore treatment protocols, drug comparisons, resistance patterns, and prevention strategies for all parasitic diseases.
Get a structured AI clinical assessment based on your symptoms — possible parasitic causes, red flags, and recommended next steps.
Start Free AI Analysis →Content on this page is informed by evidence-based clinical sources including: